你想保持单身吗? 你想保持单身吗? 关于药物开发中单臂试验和监管后空间的考虑
Yulia Dyachkova1, Cornelia Dunger-Baldauf2, Nathalie Barbier2
1Merck Healthcare KGaA, Darmstadt, Germany.
Pharmaceutical statistics
|June 26, 2024
概括
单臂试验 (SAT) 在药物开发中使用,特别是在瘤学和罕见疾病中. 本次审查审查了它们的监管接受,统计方法和最佳用于证据生成的使用.
科学领域:
- 临床试验方法论 临床试验方法论
- 药物开发 药物开发
- 卫生技术评估 卫生技术评估
背景情况:
- 单臂试验 (SAT) 在药物开发中经常被使用,尽管它不是首选的研究设计.
- 监管机构可以在特定场景中接受SAT,例如瘤学或罕见疾病,特别是当治疗效果显著且安慰剂使用不道德时.
- 然而,SAT通常用于监管批准后,其适合解决关键研究问题的适用性通常是有限的.
研究的目的:
- 审查有关SAT使用的监管和卫生技术评估 (HTA) 观点.
- 识别与使用SAT用于超越初始监管审查的研究问题相关的挑战.
- 探索不断发展的统计方法和沟通策略,以优化SAT设计和决策.
主要方法:
- 对有关SAT的监管和HTA指南的文献综述.
- 分析适用于SAT的统计方法.
- 检查例证研究,说明SAT的实用性和局限性.
- 讨论有效沟通和研究设计的策略.
主要成果:
- 监管机构对SATs的接受取决于上下文,通常需要实质性的治疗效果或伦理考虑.
- 对SAT的监管后使用在解决复杂的研究问题方面提出了重大挑战.
- 统计方法的进步有可能提高SAT数据的解释性.
- 有效的沟通和战略研究设计对于最大限度地提高SAT的价值至关重要.
结论:
- SAT在药物开发中发挥着作用,但其应用需要仔细考虑上下文和局限性.
- 需要进一步开发统计方法和明确的沟通策略,以优化SATs用于证据生成的使用.
- 战略设计和SATs的适当应用可以帮助解决特定临床环境中的关键证据需求.
相关概念视频
01:11Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
01:25Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
01:16Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
01:28Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
01:19Pharmacovigilance
817
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
817